Stereotaxis has completed installations of the world’s first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders at Helsinki University Hospital in Helsinki, Finland and Banner University Medicine Heart Institute in Phoenix, USA.
“The clinical benefits of robotics in electrophysiology have been extensively documented at our hospital over many years,” said Pekka Raatikainen, chief of electrophysiology and pacing at the Heart and Lung Center at Helsinki University Central Hospital. “With the adoption of the first Genesis systems in the world, we are proud to be a pioneer in the process of advancing robotic technology for the benefits of patients and the medical community.”
“The capabilities of robotics are growing at a rapid rate, moving us toward a paradigm shift in our practice,” said J Peter Weiss, director of ventricular arrhythmia management and robotics at Banner University Medicine Heart Institute. “I am extremely excited to play a part in bringing this advanced technology to our community of patients and heart rhythm specialists throughout Phoenix and beyond.”
Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias.
“Patients with medical conditions from the most complex to the most common seek us out for care in part because we remain on the cutting edge in technology and safety,” said Kristi McShay, assistant vice president for the Cardiovascular Line at Banner Health. “We are pleased to be the first in the nation to offer this new generation of robotics for treating heart rhythm disorders.”
“This technology allows us to positively address the increasing number of patients with complex arrhythmias. In addition, it provides us a competitive advantage to other Nordic centers concerning education and learning,” said Antti Vento, medical director of Helsinki Heart and Lung Center.